Generic Drug Market 2015

Language:
Japanese
Product Code No:
C57105900
Issued In:
2015/05
#of Pages:
372
Publication Cycle:
Biannual
Format:
PDF

Price

120,000 yen ($843.76)
(excluding consumption tax)
240,000 yen ($1,687.53)
(excluding consumption tax)
360,000 yen ($2,531.29)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 142.22 yen , 2025/04/30 Japan)
*Scope of Each License Type

Coverage: (Product/service)

Generic Drugs

Research Target:

Generic Drugs manufacturers

Research Content:

I   Generic Drugs Market in Japan

  • New goal has been set for occupying 60% share of the entire drug market in volume 
  • The generic drugs market in Japan has entered the fourth term
  • Use of generic drugs have been encoraged in FY2014 Revision of the Medical Payment System
  • Reviewing of assessing premiums to be added for generic-drugs prescription
  • Newly settled generic drug index
  • Further use of generic drugs advocated by the finance minister
  • Actual status and future perspectives of the generic drugs market
  • Forecast of market size
  • Sales of generic drugs by channel

II   Strategies on Generic Drugs in Pharmaceutical Companies

  • The generic drugs market has entered new stage
  • Nichi-Iko Pharmaceutical Co.,Ltd. became the first generic-only manufacturer to exceed 100 billion yen for the sales.
  • The generic drug Industry has been reorganizing as the time changes
  • Generic pharmaceuticals from foreign countries are gaining its existence
  • The companies from different industries that have positioned generic drugs as growing market
  • The pharmaceutical manufacturers that had started the generic drug business earlier than other companies and have entered into next new stage
  • R&D expenses and capital investment are on the rise in the generic drugs market
  • Sales have been enhanced in the generic drugs market in order to compete with the dispensing pharmacies that have recently been expanding its market
  • Alliance strategies among the generic drugs manufacturers
  • Differentiation strategies by generic drugs manufacturers
  • The subsequent bio product business on the move
  • Aiming for continuous growth, manufacturers have started targeting overseas business
  • Future outlook of the generic drugs market

III   Trends in Generic Drug Manufacturers

14 companies

IV     Generic Drugs Strategies Hammered Out by DPC Hospitals

  • Positioning of Generic Drugs in the "Abenomics" environment
  • Forecasting of changes in the medical market towards 2025

V   Company Profiles

175 enterprises

 

Price

written in Japanese
120,000 yen ($843.76)
(excluding consumption tax)
240,000 yen ($1,687.53)
(excluding consumption tax)
360,000 yen ($2,531.29)
(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 142.22 yen , 2025/04/30 Japan)
*Scope of Each License Type